ProfileGDS4718 / 240930_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 21% 25% 24% 22% 19% 18% 33% 24% 30% 22% 19% 19% 22% 26% 30% 26% 23% 15% 22% 33% 25% 24% 31% 21% 19% 20% 14% 19% 18% 15% 14% 22% 29% 26% 16% 21% 26% 21% 24% 26% 20% 17% 19% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2590123
GSM549102patient 115, normal, homogenized [OPG study]4.1823221
GSM549104patient 119, normal, homogenized [OPG study]4.3001225
GSM549108patient 138, normal, homogenized [OPG study]4.3457524
GSM549119patient 077, normal, homogenized [OPG study]4.2182822
GSM549133patient 032, cancer, homogenized [OPG study]4.075519
GSM549139patient 042, cancer, homogenized [OPG study]4.0482618
GSM549099patient 107, normal, homogenized [OPG study]4.6874633
GSM549109patient 139, normal, homogenized [OPG study]4.3109924
GSM549110patient 046, normal, homogenized [OPG study]4.5305130
GSM549114patient 063, normal, homogenized [OPG study]4.1887322
GSM549122patient 082, normal, homogenized [OPG study]4.1084119
GSM549134patient 033, cancer, homogenized [OPG study]4.1030119
GSM549136patient 036, cancer, homogenized [OPG study]4.1680222
GSM549140patient 044, cancer, homogenized [OPG study]4.3468226
GSM549111patient 047, normal, homogenized [OPG study]4.5098330
GSM549113patient 057, normal, homogenized [OPG study]4.3039126
GSM549132patient 031, cancer, homogenized [OPG study]4.2551623
GSM549137patient 038, cancer, homogenized [OPG study]3.9374315
GSM549142patient 047, cancer, homogenized [OPG study]4.3034122
GSM549100patient 110, normal, homogenized [OPG study]4.6913433
GSM549107patient 135, normal, homogenized [OPG study]4.2946325
GSM549115patient 068, normal, homogenized [OPG study]4.2385624
GSM549116patient 072, normal, homogenized [OPG study]4.5637231
GSM549120patient 078, normal, homogenized [OPG study]4.1580621
GSM549131patient 030, cancer, homogenized [OPG study]4.046219
GSM549118patient 074, normal, homogenized [OPG study]4.1440120
GSM549129patient 027, cancer, homogenized [OPG study]3.925414
GSM549123patient 088, normal, homogenized [OPG study]4.0997419
GSM549124patient 006, cancer, homogenized [OPG study]4.1056318
GSM549126patient 015, cancer, homogenized [OPG study]3.9574415
GSM549128patient 025, cancer, homogenized [OPG study]3.9133414
GSM549103patient 117, normal, homogenized [OPG study]4.2459422
GSM549117patient 073, normal, homogenized [OPG study]4.4758829
GSM549138patient 041, cancer, homogenized [OPG study]4.3420926
GSM549141patient 045, cancer, homogenized [OPG study]3.9466316
GSM549130patient 028, cancer, homogenized [OPG study]4.1996121
GSM549101patient 111, normal, homogenized [OPG study]4.3984826
GSM549105patient 128, normal, homogenized [OPG study]4.1788521
GSM549106patient 134, normal, homogenized [OPG study]4.2414724
GSM549112patient 048, normal, homogenized [OPG study]4.3526
GSM549125patient 011, cancer, homogenized [OPG study]4.1728120
GSM549127patient 024, cancer, homogenized [OPG study]4.0043617
GSM549135patient 035, cancer, homogenized [OPG study]4.0574119